ÐÓ°ÉÊÓƵ

During Chris Ash’s nearly 50 years at ÐÓ°ÉÊÓƵ, she saw modern buildings rise, leadership change and entirely new areas of study debut. She earned two degrees—a bachelor’s in history in 1972 and an MBA specializing in accounting in 1981—and worked in the geology department, ...

The Provost Scholars Program at ÐÓ°ÉÊÓƵ, The Concerned Pastors of East Cleveland, and the Case Comprehensive Cancer Center have collaborated to create the Health and Wellness Series: Staying Healthy and Living Longer. The mission of this program is to improve health promoti...

Two ÐÓ°ÉÊÓƵ School of Medicine professors have been elected to the National Academy of Medicine (NAM), one of the nation’s most esteemed societies for health and medicine. NAM membership “recognizes individuals who have demonstrated outstanding professional achievement and c...

September 30 marks Rare Cancer Day each year. But this year, the end of September was made even more meaningful to Case CCC thanks to a gift from the Jed Ian Taxel Foundation for Rare Cancer Research (JEDI). The $5 million launches CURE: The Rare Cancer Initiative at Case CCC. The gift is in memory...

It's Breast Cancer Awareness Month and G. Thomas Budd, MD, member of Case CCC's Immune Oncology Program, is getting noticed as the PI for his contribution to the vaccine created to find and attack the protein alpha-lactalbumin, an indicator of triple-negative breast cancer if found in women who are ...

As National Rare Cancer Day nears (Sept. 30), Jed Ian Taxel Foundation for Rare Cancer Research announces major gift to spur cross-country collaboration Less than six months after Jed Ian Taxel’s diagnosis with a rare metastatic cancer, he learned his treatment was ineffective. Weeks before his dea...

Awarded five-year, $3.05 million grant from National Institutes of Health, National Cancer Institute With a new five-year, $3.05 million grant from the National Institutes of Health and National Cancer Institute, researchers at the Case Comprehensive Cancer Center and University Hospitals (UH) will...

A new $2 million grant from the Mt. Sinai Health Foundation has established the Mt. Sinai Fellows in Therapeutic Discovery, an effort to support the recruitment of exceptional mid-career MD/PhD researchers to participate in an interdisciplinary collaborative that includes CWRU's hospital partners. ...

Fellows program to attract leading researchers to collaborate with university and hospital colleagues to develop promising solutions—and get them to patients After helping to launch the careers of 30 medical school researchers, the Mt. Sinai Health Foundation is partnering again with Case Western R...

Joel Saltzman, MD, a member of Case CCC's Developmental Therapeutic Program and a clinician in the Department of Hematology and Oncology at Cleveland Clinic Taussig Cancer Institute, has been named a Fellow of the American Society of Clinical Oncology (FASCO). An ASCO member is recognized as a fell...